News By Tag
News By Place
Halloween is fast approaching... Are you scared of increasing Drug Spend yet?
Frighteningly increasing Drug Spend threatens cost and quality efficiency, putting organizations at greater risk
Although they comprised only 1% of all prescriptions filled in the United States in 2014, Specialty Medication prescriptions represented 31.8% of all Drug Spend.
Dr. Craig Stern, President of Pro Pharma commented, “When this increasing drug trend is not managed concurrently and proactively it puts your organization at greater risk for detrimental situations.”
Detrimental Situations Include, but are not limited to:
· - Utilization That Overtakes Cost
· - Specialty Medication Use Becomes Uncontained
· - Quality of Care Becomes Inconsistent
“Proactive management of financial and clinical outcomes is not only good business, but is more importantly cost and quality efficient,” added Carol Stern, CEO of Pro Pharma.
Managing healthcare populations concurrently and proactively provides for:
· - Maximizing Therapeutic Benefit
· - Minimizing Clinical and Financial Risk
· - Assuring Affordable Cost for Members and Your Organization
Pro Pharma understands the challenges many organizations are facing with ever-increasing Drug Send and is proud to provide various organizations with their industry and consulting expertise; coupled with sophisticated data analytical capabilities, to formulate strategies which enhance process, performance and financial efficiencies to tackle constantly increasing Drug Spend.
Do you know the questions to ask to diagnose and treat your Drug Spend issues?
For additional information visit http://propharmaconsultants.com/
Learn how Pro Pharma Pharmaceutical Consultants, Inc. (Pro Pharma) can assist you in identifying trouble spots in Pharmacy Benefits but more importantly how to resolve and control your Drug Spend. These tools are accessible to you and your organization at an affordable cost, but more importantly are positioned to create value.
About Pro Pharma Pharmaceutical Consultants, Inc.
PRO PHARMAis a multi-service, woman owned, privately held consulting firm offering a vast portfolio of services to public and private entities including self-insured employers, Taft Hartley Trusts and unions, public employers, for-profit hospitals and integrated health networks, health care insurance companies, worker's compensation insurers, small-to-medium sized HMO's, and physician groups.
As a primary service to plan sponsors for achieving below trend results, PRO PHARMA provides an integrated program of administrative process improvements, clinical quality oversight, and provider/member education.
Pro Pharma’s Consulting services are grounded in the use of data and the communication of that information to define benefit trends, drivers and other analytical indicators. PRO PHARMA markets Comprehensive Specialty Analyses™, JCode Calculator™, Invoice Screening ™, Pro Pharma Suite of Tools™, Rx MAC List™, Quality Management Program™, Treatment Calendar™, and Biotech Modeling™. The Pro Pharma directly markets its products in the U.S. and collaborates with partners to reach international markets.
About Comprehensive Specialty Analyses™
Comprehensive Specialty Analyses™ utilizes a multi-pronged approach to analyze pharmacy and medical encounter claims through problem flagging, feedback on performance, peer to peer comparison, and others parameters. Comprehensive Specialty Analyses™ specifically identify pricing differences, usage, trends, and actionable opportunities in the medical data that were not apparent in the past. In order to achieve these goals it is necessary to view the Medical Data from multiple perspectives, i.e., a 360 degree view that allows for seeing beyond the obvious of top drugs spend and top providers as well as compare and contrast it with the Pharmacy Claims Data.
For addtional information visit http://propharmaconsultants.com/
Carol Stern, CEO